MacLeod Roderick H. 4
4 · NEVRO CORP · Filed Mar 11, 2024
Insider Transaction Report
Form 4
NEVRO CORPNVRO
MacLeod Roderick H.
SVP, Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-07+84,326→ 147,840 total - Tax Payment
Common Stock
2024-03-07$15.32/sh−7,136$109,324→ 140,704 total
Footnotes (2)
- [F1]Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on March 7, 2025 and the remainder will vest quarterly thereafter, such that all RSUs will be fully vested by the third anniversary of the grant date, subject to the Reporting Person's continued service to the issuer.
- [F2]Includes 121,763 RSUs.